News About: Pharm. Industry
Most pharmaceutical firms still sweating over 2009 plan
A majority of Korean pharmaceutical companies are still struggling to finalize their business plans for the new year, industry sources said recently.
External negative factors, such as the government's pressure to ...
Flu epidemic affects cold drug sales
With the H1N1 pandemic regaining its strength, concerns are rising that the outbreak will negatively affect the revenues of cold drug manufacturers.
The H1N1 virus' infection rate has gone up to 4,000 per day, and...
Dong-A’s Leucostim goes to Turkey
“Leucostim”, a treatment for neutropenia, is to be export to Turkey, Dong-A Pharmaceutical has announced on October 28.
It is going to export $20 million's worth of Leucostim to DEM ilac in Turkey for the next five...
Factive’s side effect cases top 34 for 6 years
The Korea Food and Drug Administration says that of 3,972 patients, a total of 34 cases of side-effects caused by Factive (gemifloxacin mesylate) have been reported for the recent six years (2003 to 2008).
It is ba...
Pharmaceutical stocks turning bullish on influenza A
Influenza A formerly known as swine flu, appears to have benefited some corporations in the medical and healthcare industries.
Shares of Myungmoon Pharm increased consecutively to its daily limits for October 27 an...
Dong-A, Daewoong enjoy brisk sales in domestic antiulcerant market
Dong-A Pharmaceutical and Daewoong Pharm saw their sales of Stillen and Albis soar in the third quarter of this year, according to market data.
Dong-A garnered 62.1 billion won in the accumulated nine-month of sale...
Yoon stress revival of entrepreneurial spirit
Yoon Do-jun, incumbent chairman of Dongwha Pharmaceutical, said on October 26 reviving an entrepreneurial spirit is the key to to stay alive much longer.
In his key-note address in an international conference title...
LG Life Sciences develops innovative cytoprotective agent
LG Life Sciences Ltd. said on October 27 it will carry out the phase 1 clinical study of a drug for the treatment of stroke and myocardial infarction, in collaboration with Asan Medical Center.
The company said it ...
Daehwa gets Canada patent for oral paclitaxel
Daehwa Pharm said on October 26 that it has recently won Canada patent covering the oral form of widely used cancer drug paclitaxel, which is normally administered through injection, following its patent acquisition i...
Multinational firms urged to promote fair competition atmosphere
Domestic pharmaceutical wholesalers are vehemently criticizing the approaches of multinational drug manufacturers to allow their products to be sold by Zuellig Pharma Korea.
Their reaction came out after Pfizer Kor...
